Advanced Medical Research Center

Global Deposition Equipment Market Expected to Reach US$25.77 Billion in 2023, Surging at a CAGR of 13.75% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 1, 2023
Engineering, Chemicals, Plastics, Manufacturing, Internet of things, ALD, Growth, Silicon, Data storage, Electroplating, LPCVD, Use, Deposition, Sputtering, Internet, Artificial intelligence, Tablet, USB On-The-Go, LED, MOCVD, COVID-19, Intellectual property protection in consumer electronics industry, Advanced Medical Research Center, Electronics, PECVD, Automotive industry, Semiconductor, The central science, Compound annual growth rate, Rare-earth element, Renewable energy, Medical device

The adoption of deposition equipment is driven by several key factors:

Key Points: 
  • The adoption of deposition equipment is driven by several key factors:
    By Type: The global deposition equipment market is categorized into eight segments: PECVD, Sputtering PVD, Tubular CVD, Non-tubular LPCVD, ALD, MOCVD, Electroplating ECD, and Other.
  • The global deposition equipment market extends across four major regions: Asia Pacific, North America, Europe, and the Rest of the World.
  • Growing Global Demand For Photovoltaic Cells: The increasing global awareness of renewable energy sources drives the need for photovoltaic cells, stimulating the deposition equipment market.
  • The global deposition equipment market is characterized by consolidation, with prominent players including:

Deposition Equipment Revolutionizes Opto-Electronic and Medical Manufacturing: Driving Growth and Innovation

Retrieved on: 
Thursday, November 2, 2023
Internet of things, ALD, Growth, Silicon, Data storage, Electroplating, LPCVD, Use, Deposition, Sputtering, Internet, Artificial intelligence, Tablet, USB On-The-Go, LED, MOCVD, COVID-19, Intellectual property protection in consumer electronics industry, Advanced Medical Research Center, Electronics, PECVD, Automotive industry, Semiconductor, The central science, Compound annual growth rate, Rare-earth element, Renewable energy, Medical device

The adoption of deposition equipment is driven by several key factors:

Key Points: 
  • The adoption of deposition equipment is driven by several key factors:
    By Type: The global deposition equipment market is categorized into eight segments: PECVD, Sputtering PVD, Tubular CVD, Non-tubular LPCVD, ALD, MOCVD, Electroplating ECD, and Other.
  • Escalating Use of Advanced Medical Equipment: The healthcare industry's increasing adoption of advanced medical equipment further drives the demand for deposition equipment in the production of these devices.
  • High Cost Associated with Deposition Equipment Manufacturing: The complexity and precision of deposition equipment manufacturing come with a high cost, which can be a challenge for market players.
  • Escalation of Internet of Things (IoT): IoT's growth requires advanced semiconductor manufacturing, contributing to the demand for deposition equipment.

Homestead Smart Health Plans Appoints John Powers as CEO

Retrieved on: 
Wednesday, July 19, 2023
Advanced Medical Research Center, EVP, Partner, Health, AMPS, Capital, Management

PHILADELPHIA, July 19, 2023 /PRNewswire/ -- Homestead Smart Health Plans is pleased to announce the appointment of John Powers as Chief Executive Officer.

Key Points: 
  • PHILADELPHIA, July 19, 2023 /PRNewswire/ -- Homestead Smart Health Plans is pleased to announce the appointment of John Powers as Chief Executive Officer.
  • Homestead Smart Health Plans, an organization dedicated to offering transparent and sustainable solutions for employers to address the rising cost of healthcare, today announces the appointment of John Powers as the company's Chief Executive Officer.
  • Powers is a senior healthcare executive with over 25 years' experience, including over a decade of leadership growing the reference-based pricing market.
  • I'm proud of what this team has worked together to accomplish over the past year - driving innovation with all 3 of our integrated solutions: Homestead Smart Health Plans, Claim Watcher Reference Based Pricing and Homestead Insurance Company," said Powers.

Nihon Kohden Introduces CoMET to Help Detect Early Warning of Patient Illness Through Artificial Intelligence

Retrieved on: 
Wednesday, January 18, 2023
Technology, Medical Devices, Hospitals, Health Technology, Cardiology, Practice Management, Biometrics, Biotechnology, Health, Artificial Intelligence, Continuous monitoring, Hospital, Vital signs, Disease, Intubation, Machine learning, Risk, Diagnosis, Advanced Medical Research Center, Patient, Sepsis, Artificial intelligence, Bleeding, Community of Metros, Acquisition, Cardiogenic shock, Medical device, Pharmaceutical industry, Nihon Kohden

Nihon Kohden acquired CoMET technology through its acquisition of AMP3D (Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.) last year.

Key Points: 
  • Nihon Kohden acquired CoMET technology through its acquisition of AMP3D (Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.) last year.
  • CoMET’s event trajectories provide clinicians with a visual tool for identifying potential patient deterioration, monitoring treatment efficacy, assessing patient acuity, and managing appropriate staffing ratios.
  • The Artificial Intelligence tool can also rank patients according to predicted risk of severe illness and display trajectories of deterioration and recovery.
  • Beyond the world’s first pulse oximeter, Nihon Kohden leverages its 70-year heritage to set the bar high, with industry-changing innovation for experts by experts.

RxBenefits Names Thad Kwiatkowski Chief Financial Officer

Retrieved on: 
Monday, November 21, 2022
Growth, Virtual CFO, Health, AMPS, PBM, Information technology, Pharmacy, Safety, Consultant, CFO, PBO, Strategic planning, Risk, Advanced Medical Research Center, Management, Kwiatkowski, Thad

BIRMINGHAM, Ala., Nov. 21, 2022 /PRNewswire-PRWeb/ -- Today, RxBenefits, the employee benefits industry's first technology-enabled pharmacy benefits optimizer (PBO), announced Thad Kwiatkowski has been named Chief Financial Officer (CFO). A senior-level executive with more than 20 years of finance, administrative and accounting experience in a variety of industries, including healthcare, Kwiatkowski's financial acumen and strategic leadership expertise will further accelerate the company's strategic initiatives and support its long-term growth.

Key Points: 
  • Leading pharmacy benefits optimizer appoints 20-year executive finance veteran, further bolstering its seasoned leadership bench; Robert Gamble transitioning to President and Chief Operating Officer
    BIRMINGHAM, Ala., Nov. 21, 2022 /PRNewswire-PRWeb/ -- Today, RxBenefits , the employee benefits industry's first technology-enabled pharmacy benefits optimizer (PBO) , announced Thad Kwiatkowski has been named Chief Financial Officer (CFO).
  • A self-described servant leader, Kwiatkowski most recently served as CFO at Advanced Medical Pricing Solutions (AMPS), a leader in healthcare cost containment.
  • In his role as CFO at RxBenefits, Kwiatkowski will nourish RxBenefits' best-in-class culture, utilizing his vast experience to transform existing financial and operational data into business decisions that will further fuel the company's growth.
  • With Kwiatkowski's hire, current President and Chief Financial Officer, Robert Gamble will complete his planned executive transition to President and Chief Operating Officer (COO).

United Imaging Ships Global Installations Number 20,000, 20,001 and 20,002 from its Houston Headquarters to New York City

Retrieved on: 
Wednesday, October 12, 2022
Physician, LinkedIn, Steam, UMR, Growth, Science, OMEGA, UAI, Shanghai Stock Exchange, Advanced Medical Research Center, IPO, Patient, Twitter, Radiology, CT, Molecular imaging, Google Images, ATLAS, CEO, PET/CT, Health, PET, Shanghai Stock Exchange STAR Market, Radiation, University, FDA, Solution, Star Market, Medical imaging

HOUSTON, Oct. 12, 2022 /PRNewswire/ -- United Imaging, a global leader in producing advanced medical imaging and radiotherapy equipment, announced that it is now shipping its 20,000th installation and two additional installations to Manhattan, where a new advanced medical imaging clinic will soon open its doors.    

Key Points: 
  • The three installations are the uMR OMEGA(magnetic resonance), the uCTATLAS (computed tomography), and the uMI550 (molecular imaging).
  • They are being crated and shipped from United Imaging's nearly 100,000 square foot factory, showroom, and U.S. headquarters in Houston.
  • "Just two and a half years ago we announced our 8,500th global installation," said Jeffrey M. Bundy, Ph.D, CEO of United Imaging Healthcare Solutions.
  • We can create the best plans for our patients by working with United Imaging, making full use of their superior imaging technologies."

United States Cryostat Market Analysis Report 2022-2027: Growing Demand in Aerospace Applications & Increasing Usage of Natural Gas Pipelines - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 14, 2022
Medical Devices, Health, Competitive analysis, Risk, COVID-19, Advanced Medical Research Center, Growth, Ansoff Matrix, Impact, Market development, USD, Investment, Emotion, SWOT, AMOS, CAGR, Marketing, Risk management, Industry

Market dynamics are forces that impact the prices and behaviors of the US Cryostat Market stakeholders.

Key Points: 
  • Market dynamics are forces that impact the prices and behaviors of the US Cryostat Market stakeholders.
  • These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service.
  • The report presents a detailed Ansoff matrix analysis for the US Cryostat Market.
  • Based on the SWOT analysis conducted on the industry and industry players, The analyst has devised suitable strategies for market growth.

Outlook on the Cryostat Global Market to 2027 - Growing Demand in Aerospace Applications Presents Opportunities

Retrieved on: 
Tuesday, July 12, 2022
Market development, COVID-19, Advanced Medical Research Center, Ansoff Matrix, SWOT, Impact, Geography, Risk, Observation, Porter's five forces analysis, USD, Investment, AMOS, CAGR, Competitive analysis, Growth, Emotion, Retail, Risk management, Pharmaceutical industry, Industry

The Global Cryostat Market is estimated to be USD 3.09 Bn in 2022 and is projected to reach USD 4.31 Bn by 2027, growing at a CAGR of 6.89%.

Key Points: 
  • The Global Cryostat Market is estimated to be USD 3.09 Bn in 2022 and is projected to reach USD 4.31 Bn by 2027, growing at a CAGR of 6.89%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Cryostat Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Cryostat Market.
  • The analyst analyses the Global Cryostat Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Homestead Smart Health Plans Announces President, John Powers

Retrieved on: 
Thursday, June 30, 2022
Knowledge, Solution, Advanced Medical Research Center, AMPS, CEO, EVP, Multimedia, Management

PHILADELPHIA, June 29, 2022 /PRNewswire/ -- Homestead Smart Health Plans is pleased to announce the appointment of John Powers as President of Homestead.

Key Points: 
  • PHILADELPHIA, June 29, 2022 /PRNewswire/ -- Homestead Smart Health Plans is pleased to announce the appointment of John Powers as President of Homestead.
  • Bill Green, CEO, Homestead Smart Health Plans
    "I could not be more excited to join Homestead's already successful team," Powers said.
  • I could not be more confident that I can use my experience to help take Homestead Smart Health Plans to the next level."
  • Homestead Smart Health Plans was formed by health insurance industry insiders from some of the biggest names in the business to solve the core problem of rising costs and decreasing coverage.

Rhino Health Platform Powers Hospital-Based Federated Learning Consortium

Retrieved on: 
Thursday, May 5, 2022
Innovation, American College, MGH, Health, Algorithm, Master of Philosophy, Protocol, Superintendent, Federated, Adoption, Massachusetts General Hospital, Informatics, CEO, AI, Genomic and Medical Data, Medical imaging, Patient, National Taiwan University, Seoul National University Hospital, Hospital, Research fellow, Center, American College of Radiology, Medical Center, Assuta Medical Center, FRCP, Associate, Institute, Advanced Medical Research Center, MBA, FRCR, Bias, Ownership, Privacy, Lahey Hospital & Medical Center, GLOBE, Review, Harvard Medical School, Dasa, Medical device, Pharmaceutical industry, Management, Radiology, Doctor of Philosophy, MD

BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Rhino Health , a distributed compute platform leveraging the privacy-preserving federated learning concept, today announced a hospital-based federated learning for medicine consortium, Federated Learning for Medicine (FL4M).

Key Points: 
  • BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Rhino Health , a distributed compute platform leveraging the privacy-preserving federated learning concept, today announced a hospital-based federated learning for medicine consortium, Federated Learning for Medicine (FL4M).
  • Developers are training AI models across a federated network of seven global hospitals - using federated learning powered by Rhino Health, so that the patient data never leaves the original hospital site.
  • "Rhino Health is proud to support medical researchers around the globe," said Ittai Dayan, MD, CEO and Co-Founder of Rhino Health.
  • Grounded in federated learning, Rhino Health makes it possible to collaborate without ever moving data, transferring ownership, or risking patient privacy.